We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.49B
AUM Growth
+$329M
(+5.3%)
Cap. Flow
+$1.05B
Cap. Flow
% of AUM
16.14%
Top 10 Holdings %
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$112M |
| 2 |
Skyworks Solutions
SWKS
|
+$103M |
| 3 |
STMicroelectronics
STM
|
+$87.3M |
| 4 |
ASML
ASML
|
+$71.6M |
| 5 |
Palo Alto Networks
PANW
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$169M |
| 2 |
Cooper Companies
COO
|
+$103M |
| 3 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$102M |
| 4 |
Lam Research
LRCX
|
+$78.9M |
| 5 |
KLA
KLAC
|
+$76.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.94% |
| 2 | Technology | 31.31% |
| 3 | Financials | 8.29% |
| 4 | Industrials | 7.52% |
| 5 | Communication Services | 4.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Lattice Semiconductor
LSCC
$17.6B
| $9.93M | 0.15% |
204,820
+189,844
| +1,268% | +$9.45M |
|
177
Option Care Health
OPCH
$3.45B
| $9.93M | 0.15% |
357,217
+200,032
| +127% | +$5.69M |
|
|
DICE
178
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $9.89M | 0.15% |
636,987
-12,166
| -2% | -$209K |
|
179
Ascendis Pharma A/S
ASND
$16B
| $9.87M | 0.15% |
106,126
-5,886
| -5% | -$555K |
|
180
PTC Therapeutics
PTCT
$5.68B
| $9.82M | 0.15% |
245,260
+36,767
| +18% | +$1.29M |
|
|
DMYS
181
DELISTED
dMY Technology Group, Inc. VI
DMYS
| $9.78M | 0.15% |
1,000,000
| – | – |
|
182
Fox Class A
FOXA
$24.5B
| $9.71M | 0.15% |
302,074
-187,577
| -38% | -$6.6M |
|
183
Nice
NICE
$5.79B
| $9.5M | 0.15% |
49,358
-13,130
| -21% | -$2.66M |
|
184
CVS Health
CVS
$133B
| $9.43M | 0.15% |
+101,804
| New | +$9.94M |
|
185
Gossamer Bio
GOSS
$82.9M
| $9.43M | 0.15% |
1,126,809
+822,780
| +271% | +$6.38M |
|
186
Nokia
NOK
$51B
| $9.39M | 0.14% |
2,037,143
-1,679,663
| -45% | -$8.39M |
|
187
FIVE9
FIVN
$2.11B
| $9.37M | 0.14% |
+102,839
| New | +$10.4M |
|
188
Henry Schein
HSIC
$9.77B
| $9.13M | 0.14% |
118,960
-40,503
| -25% | -$3.39M |
|
|
IMGO
189
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $9M | 0.14% |
672,060
-159,770
| -19% | -$2.54M |
|
|
GTHX
190
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $8.88M | 0.14% |
+1,797,182
| New | +$9.95M |
|
191
Planet Fitness
PLNT
$4.42B
| $8.79M | 0.14% |
+129,189
| New | +$9.55M |
|
192
Zymeworks
ZYME
$1.61B
| $8.7M | 0.13% |
1,641,876
-574,186
| -26% | -$3.47M |
|
193
Aclaris Therapeutics
ACRS
$726M
| $8.68M | 0.13% |
+621,557
| New | +$8.71M |
|
194
BILL Holdings
BILL
$4.49B
| $8.65M | 0.13% |
+78,677
| New | +$11.5M |
|
195
Sana Biotechnology
SANA
$871M
| $8.51M | 0.13% |
1,323,233
-228,707
| -15% | -$1.46M |
|
|
RBAC
196
DELISTED
RedBall Acquisition Corp.
RBAC
| $8.47M | 0.13% |
850,000
+250,000
| +42% | +$2.48M |
|
|
PRPB
197
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $8.29M | 0.13% |
+830,000
| New | +$8.25M |
|
198
ARK Innovation ETF
ARKK
$5.66B
| $8.13M | 0.13% |
+203,980
| New | +$9.71M |
|
199
VeriSign
VRSN
$26.2B
| $8.06M | 0.12% |
48,168
-31,220
| -39% | -$5.73M |
|
|
SNRH
200
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
| $8.06M | 0.12% |
818,975
| – | – |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.
- Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
- Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
- Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
- Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
- Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
- Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
- Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.
Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.